                </a></li></ul></div><p><strong>Figure 1.  <span>JAK2 V617F induces polycythemia through autonomous overproduction of erythrocytes.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>(A–C): Hematocrit (A), blood hemoglobin (B), and reticulocyte counts (C) from cohorts of Balb/c or B6 mice transplanted with syngeneic BM cells transduced with empty vector (green, <em>n</em> = 2), or retrovirus expressing murine JAK2 WT (blue, <em>n</em> = 10) or JAK2 V617F (red, <em>n</em> = 15).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p2" name="article1.body1.sec3.sec1.fig1.caption1.p2"></a><p>In the case of the B6 cohorts, untransplanted mice (“Normal”, <em>n</em> = 4) were used instead of empty vector controls.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p3" name="article1.body1.sec3.sec1.fig1.caption1.p3"></a><p>The difference between JAK2 V617F and JAK2 WT recipients was significant (unpaired <em>t</em>-test) for hematocrit (<em>P</em>&lt;0.0001 for Balb/c and <em>P</em> = 0.0071 for B6), hemoglobin (<em>P</em> = 0.0011 for Balb/c and <em>P</em> = 0.0024 for B6), and reticulocytes (<em>P</em>&lt;0.0001 for Balb/c and <em>P</em> = 0.0195 for B6), while there were no significant differences between vector and JAK2 WT recipients.</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p4" name="article1.body1.sec3.sec1.fig1.caption1.p4"></a><p>(D) Reticulocyte stains of peripheral blood from recipients of BM transduced with JAK2 WT (left) or JAK2 V617F (right).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p5" name="article1.body1.sec3.sec1.fig1.caption1.p5"></a><p>(E–F): Erythrocyte survival curves (E) and red cell mass determination (F) for the three groups (Balb/c background).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p6" name="article1.body1.sec3.sec1.fig1.caption1.p6"></a><p>The red cell mass of JAK2 V617F recipients was significantly greater than that of recipients of vector- or JAK2 WT-transduced BM (<em>P</em> = 0.0068 and <em>P</em> = 0.0009, respectively, unpaired <em>t</em>-test).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p7" name="article1.body1.sec3.sec1.fig1.caption1.p7"></a><p>(G) Plasma Epo levels for the three groups (B6 background).</p>
<a id="article1.body1.sec3.sec1.fig1.caption1.p8" name="article1.body1.sec3.sec1.fig1.caption1.p8"></a><p>The mean Epo level (bar) of JAK2 V617F recipients was significantly lower than that of recipients of vector- or JAK2 WT-transduced BM (<em>P</em> = 0.0048 and <em>P</em> = 0.0151, respectively, unpaired <em>t</em>-test).</p>
